1
|
Garzón V, Bustos RH, G. Pinacho D. Personalized Medicine for Antibiotics: The Role of Nanobiosensors in Therapeutic Drug Monitoring. J Pers Med 2020; 10:E147. [PMID: 32993004 PMCID: PMC7712907 DOI: 10.3390/jpm10040147] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2020] [Revised: 09/05/2020] [Accepted: 09/07/2020] [Indexed: 01/01/2023] Open
Abstract
Due to the high bacterial resistance to antibiotics (AB), it has become necessary to adjust the dose aimed at personalized medicine by means of therapeutic drug monitoring (TDM). TDM is a fundamental tool for measuring the concentration of drugs that have a limited or highly toxic dose in different body fluids, such as blood, plasma, serum, and urine, among others. Using different techniques that allow for the pharmacokinetic (PK) and pharmacodynamic (PD) analysis of the drug, TDM can reduce the risks inherent in treatment. Among these techniques, nanotechnology focused on biosensors, which are relevant due to their versatility, sensitivity, specificity, and low cost. They provide results in real time, using an element for biological recognition coupled to a signal transducer. This review describes recent advances in the quantification of AB using biosensors with a focus on TDM as a fundamental aspect of personalized medicine.
Collapse
Affiliation(s)
- Vivian Garzón
- PhD Biosciences Program, Universidad de La Sabana, Chía 140013, Colombia;
| | - Rosa-Helena Bustos
- Therapeutical Evidence Group, Clinical Pharmacology, Universidad de La Sabana, Chía 140013, Colombia;
| | - Daniel G. Pinacho
- Therapeutical Evidence Group, Clinical Pharmacology, Universidad de La Sabana, Chía 140013, Colombia;
| |
Collapse
|
2
|
Garzón V, Pinacho DG, Bustos RH, Garzón G, Bustamante S. Optical Biosensors for Therapeutic Drug Monitoring. Biosensors (Basel) 2019; 9:E132. [PMID: 31718050 PMCID: PMC6955905 DOI: 10.3390/bios9040132] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/04/2019] [Revised: 10/30/2019] [Accepted: 11/01/2019] [Indexed: 12/26/2022]
Abstract
Therapeutic drug monitoring (TDM) is a fundamental tool when administering drugs that have a limited dosage or high toxicity, which could endanger the lives of patients. To carry out this monitoring, one can use different biological fluids, including blood, plasma, serum, and urine, among others. The help of specialized methodologies for TDM will allow for the pharmacodynamic and pharmacokinetic analysis of drugs and help adjust the dose before or during their administration. Techniques that are more versatile and label free for the rapid quantification of drugs employ biosensors, devices that consist of one element for biological recognition coupled to a signal transducer. Among biosensors are those of the optical biosensor type, which have been used for the quantification of different molecules of clinical interest, such as antibiotics, anticonvulsants, anti-cancer drugs, and heart failure. This review presents an overview of TDM at the global level considering various aspects and clinical applications. In addition, we review the contributions of optical biosensors to TDM.
Collapse
Affiliation(s)
- Vivian Garzón
- Doctoral Programme of Biosciences, Universidad de La Sabana, Chía 140013, Colombia
- Therapeutic Evidence Group, Clinical Pharmacology, Universidad de La Sabana, Chía 140013, Colombia
| | - Daniel G. Pinacho
- Therapeutic Evidence Group, Clinical Pharmacology, Universidad de La Sabana, Chía 140013, Colombia
| | - Rosa-Helena Bustos
- Therapeutic Evidence Group, Clinical Pharmacology, Universidad de La Sabana, Chía 140013, Colombia
| | - Gustavo Garzón
- Faculty of Medicine, Universidad de La Sabana, Chía 140013, Colombia
| | - Sandra Bustamante
- Physics Department, the Centre for NanoHealth, Swansea University, Swansea SA2 8PP, UK
- Vedas, Corporación de Investigación e Innovación, Medellín 050001, Colombia
| |
Collapse
|
9
|
Giroud F, Gorgy K, Gondran C, Cosnier S, Pinacho DG, Marco MP, Sánchez-Baeza FJ. Impedimetric Immunosensor Based on a Polypyrrole−Antibiotic Model Film for the Label-Free Picomolar Detection of Ciprofloxacin. Anal Chem 2009; 81:8405-9. [DOI: 10.1021/ac901290m] [Citation(s) in RCA: 62] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Fabien Giroud
- Département de Chimie Moléculaire UMR-5250, ICMG FR-2607, CNRS, Université Joseph Fourier, BP-53, 38041 Grenoble Cedex 9, France, and Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona, 18-26, 08034-Barcelona, Spain
| | - Karine Gorgy
- Département de Chimie Moléculaire UMR-5250, ICMG FR-2607, CNRS, Université Joseph Fourier, BP-53, 38041 Grenoble Cedex 9, France, and Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona, 18-26, 08034-Barcelona, Spain
| | - Chantal Gondran
- Département de Chimie Moléculaire UMR-5250, ICMG FR-2607, CNRS, Université Joseph Fourier, BP-53, 38041 Grenoble Cedex 9, France, and Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona, 18-26, 08034-Barcelona, Spain
| | - Serge Cosnier
- Département de Chimie Moléculaire UMR-5250, ICMG FR-2607, CNRS, Université Joseph Fourier, BP-53, 38041 Grenoble Cedex 9, France, and Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona, 18-26, 08034-Barcelona, Spain
| | - Daniel G. Pinacho
- Département de Chimie Moléculaire UMR-5250, ICMG FR-2607, CNRS, Université Joseph Fourier, BP-53, 38041 Grenoble Cedex 9, France, and Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona, 18-26, 08034-Barcelona, Spain
| | - M.-Pilar Marco
- Département de Chimie Moléculaire UMR-5250, ICMG FR-2607, CNRS, Université Joseph Fourier, BP-53, 38041 Grenoble Cedex 9, France, and Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona, 18-26, 08034-Barcelona, Spain
| | - Francisco J. Sánchez-Baeza
- Département de Chimie Moléculaire UMR-5250, ICMG FR-2607, CNRS, Université Joseph Fourier, BP-53, 38041 Grenoble Cedex 9, France, and Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona, 18-26, 08034-Barcelona, Spain
| |
Collapse
|
11
|
Tsekenis G, Garifallou GZ, Davis F, Millner PA, Pinacho DG, Sanchez-Baeza F, Marco MP, Gibson TD, Higson SPJ. Detection of Fluoroquinolone Antibiotics in Milk via a Labeless Immunoassay Based upon an Alternating Current Impedance Protocol. Anal Chem 2008; 80:9233-9. [DOI: 10.1021/ac8014752] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Georgios Tsekenis
- Cranfield Health, Cranfield University, Silsoe, Bedfordshire, MK45 4DT, U.K., School of Biochemistry and Molecular Biology, University of Leeds, Leeds, LS2 9JT, U.K., Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona 18-26, 08034-Barcelona, Spain, and T and D Technology Ltd., Wakefield, West Yorkshire, WF3 4AA, U.K
| | - Goulielmos-Zois Garifallou
- Cranfield Health, Cranfield University, Silsoe, Bedfordshire, MK45 4DT, U.K., School of Biochemistry and Molecular Biology, University of Leeds, Leeds, LS2 9JT, U.K., Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona 18-26, 08034-Barcelona, Spain, and T and D Technology Ltd., Wakefield, West Yorkshire, WF3 4AA, U.K
| | - Frank Davis
- Cranfield Health, Cranfield University, Silsoe, Bedfordshire, MK45 4DT, U.K., School of Biochemistry and Molecular Biology, University of Leeds, Leeds, LS2 9JT, U.K., Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona 18-26, 08034-Barcelona, Spain, and T and D Technology Ltd., Wakefield, West Yorkshire, WF3 4AA, U.K
| | - Paul A. Millner
- Cranfield Health, Cranfield University, Silsoe, Bedfordshire, MK45 4DT, U.K., School of Biochemistry and Molecular Biology, University of Leeds, Leeds, LS2 9JT, U.K., Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona 18-26, 08034-Barcelona, Spain, and T and D Technology Ltd., Wakefield, West Yorkshire, WF3 4AA, U.K
| | - Daniel G. Pinacho
- Cranfield Health, Cranfield University, Silsoe, Bedfordshire, MK45 4DT, U.K., School of Biochemistry and Molecular Biology, University of Leeds, Leeds, LS2 9JT, U.K., Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona 18-26, 08034-Barcelona, Spain, and T and D Technology Ltd., Wakefield, West Yorkshire, WF3 4AA, U.K
| | - Francisco Sanchez-Baeza
- Cranfield Health, Cranfield University, Silsoe, Bedfordshire, MK45 4DT, U.K., School of Biochemistry and Molecular Biology, University of Leeds, Leeds, LS2 9JT, U.K., Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona 18-26, 08034-Barcelona, Spain, and T and D Technology Ltd., Wakefield, West Yorkshire, WF3 4AA, U.K
| | - M.-Pilar Marco
- Cranfield Health, Cranfield University, Silsoe, Bedfordshire, MK45 4DT, U.K., School of Biochemistry and Molecular Biology, University of Leeds, Leeds, LS2 9JT, U.K., Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona 18-26, 08034-Barcelona, Spain, and T and D Technology Ltd., Wakefield, West Yorkshire, WF3 4AA, U.K
| | - Tim D. Gibson
- Cranfield Health, Cranfield University, Silsoe, Bedfordshire, MK45 4DT, U.K., School of Biochemistry and Molecular Biology, University of Leeds, Leeds, LS2 9JT, U.K., Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona 18-26, 08034-Barcelona, Spain, and T and D Technology Ltd., Wakefield, West Yorkshire, WF3 4AA, U.K
| | - Séamus P. J. Higson
- Cranfield Health, Cranfield University, Silsoe, Bedfordshire, MK45 4DT, U.K., School of Biochemistry and Molecular Biology, University of Leeds, Leeds, LS2 9JT, U.K., Applied Molecular Receptors Group (AMRg), CSIC, CIBER of Bioengineering, Biomaterials and Nanomedicine, Jorge Girona 18-26, 08034-Barcelona, Spain, and T and D Technology Ltd., Wakefield, West Yorkshire, WF3 4AA, U.K
| |
Collapse
|